Hi, does anyone know about Novartis Pluvicto and current sales. I read that Telix Therpy for prostate not really a big deal for SP as Novartis has the dominance. I thought this would be big deal for TLX.
seems most of the value is in the Kidney therapy with potential wider applications.
I was a little surprised to read this and thought Prostate therapy was a big deal for TLX.
TIA
Understanding Telix, page-194
-
- There are more pages in this discussion • 1,380 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.45 |
Change
0.060(0.29%) |
Mkt cap ! $6.844B | |||
| Open | High | Low | Value | Volume |
| $20.63 | $20.72 | $20.10 | $11.05M | 539.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17405 | $20.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.58 | 1490 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| TLX (ASX) Chart |